Kaya Holdings, Inc. (KAYS)
OTCMKTS · Delayed Price · Currency is USD
0.0204
-0.0032 (-13.40%)
Jul 25, 2025, 3:49 PM EDT
Kaya Holdings Market Cap
Kaya Holdings has a market cap or net worth of $845.84 thousand as of July 25, 2025. Its market cap has increased by 30.64% in one year.
Market Cap
845.84K
Enterprise Value
7.83M
Revenue
14.19K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since January 7, 2010, Kaya Holdings's market cap has increased from 10.13K to 845.84K, an increase of 8,253.96%. That is a compound annual growth rate of 32.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 976.77K | -16.09% |
| Dec 31, 2024 | 1.16M | 24.70% |
| Dec 29, 2023 | 933.48K | -33.27% |
| Dec 30, 2022 | 1.40M | -28.34% |
| Dec 31, 2021 | 1.95M | -64.91% |
| Dec 31, 2020 | 5.56M | -45.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 588.81M |
| Glass House Brands | 411.26M |
| Northwest Biotherapeutics | 382.85M |
| CytoDyn | 362.86M |